Skip to main content
. 2016 Dec 16;13(2):912–920. doi: 10.3892/ol.2016.5512

Table I.

Baseline general characteristics among all patients and by mean EGFR score index punctuation.

Mean EGFR-score index punctuation Mean EGFR-score index punctuation


Characteristic Overall (n=85) Mean (± SD; mean EGFR) score=125.41±96.36 P-value <100 (n=39) ≥100 (n=46) P-value <200 (n=61) ≥200 (n=24) P-value
Gender 0.096 0.048a 0.123a
  Male 42.4 (36/85) 105.09 (±88.18) 53.8 (21/39) 32.6 (15/46) 47.5 (29/61) 29.2 (7/24)
  Female 57.6 (49/85) 140.34 (±100.21) 46.2 (18/39) 67.4 (31/46) 52.5 (32/61) 70.8 (17/24)
Mean age (± SD) 61.76 (12.97) 62.3 (13.88) 61.28 (12.28) 0.712b 62.54 (13.67) 59.79 (11.02) 0.382a
Median age, years 0.231 0.849a 0.113a
  <60 44.7 (38/85) 138.38 (±97.82) 43.6 (17/39) 45.7 (21/46) 39.3 (24/61) 58.3 (14/24)
  ≥60 55.3 (47/85) 114.11 (±94.69) 56.4 (22/39) 54.3 (25/46) 60.7 (37/61) 41.7 (10/24)
Smoking exposure 0.252 0.288a 0.106a
  Non-smoker 40.0 (34/85) 141.47 (±108.33) 33.3 (13/39) 45.7 (21/46) 34.4 (21/61) 54.2 (13/24)
  Smoker 60.0 (51/85) 116.86 (±86.44) 66.6 (26/39) 54.3 (25/46) 65.6 (40/61) 45.8 (11/24)
Tobacco index 0.384b 0.696b
  Mean (± SD) 27.57 (36.67) 22.99 (18.44) 32.16 (48.78) 26.48 (30.70) 31.45 (55.04)
Wood-smoke exposure 0.488 0.514a 0.936a
  Absent 57.6 (49/85) 131.66 (±88.74) 53.8 (21/39) 60.9 (28/46) 57.4 (35/61) 58.3 (14/24)
  Present 42.4 (36/85) 116.89 (±106.55) 46.2 (18/39) 39.1 (18/46) 42.6 (26/61) 41.7 (10/24)
Wood-smoke index 0.193b 0.696b
  Mean (± SD) 90.41 (100.68) 68.38 (72.94) 112.44 (120.50) 73.18 (81.17) 135.20 (134.28)
Asbestos exposure 0.131 0.155a 0.976a
  Absent 83.5 (71/85) 118.38 (±97.45) 89.7 (35/39) 78.3 (36/46) 83.6 (51/61) 83.3 (20/24)
  Present 16.5 (14/85) 161.07 (±84.99) 10.3 (4/39) 21.7 (10/46) 16.4 (10/61) 16.7 (4/24)
Histology 0.974 0.883a 0.344a
  Adenocarcinoma 77.6 (66/85) 125.22 (±97.14) 76.9 (30/39) 78.3 (36/46) 80.3 (49/61) 70.8 (17/24)
  Other 22.4 (19/85) 126.05 (±96.18) 23.1 (9/39) 21.7 (10/46) 19.7 (12/61) 29.2 (7/24)
Disease stage 0.776 0.614a 0.882a
  II–III 17.6 (15/85) 131.73 (±93.90) 15.4 (6/39) 19.6 (9/46) 18.0 (11/61) 16.7 (4/24)
  IV 82.4 (70/85) 124.02 (±97.48) 84.6 (33/39) 80.4 (37/46) 82.0 (50/61) 83.3 (20/24)
ECOG PS 0.131 0.227a 0.158a
  0–1 82.4 (70/85) 132.73 (±95.96) 76.9 (30/39) 87.0 (40/46 78.7 (48/61) 91.7 (22/24)
  2–3 17.6 (15/85) 91.22 (±93.80) 23.1 (9/39) 13.0 (6/46) 21.3 (13/61) 8.3 (2/24)
Pleural effusion 0.396 0.406a 0.515a
  Yes 61.2 (52/33) 132.53 (±93.26) 56.4 (22/39) 65.2 (30/46) 59.0 (36/61) 66.7 (16/24)
  No 38.8 (33/85) 114.19 (±101.48) 43.6 (17/39) 38.4 (16/46) 41.0 (25/61) 33.3 (8/24)
PB-CT 0.955 0.748a 0.969a
  No 24.7 (21/85) 124.36 (±106.61) 23.1 (9/39) 26.1 (12/46) 24.6 (16/61) 25.0 (6/24)
  Yes 75.3 (64/85) 125.75 (±95.40) 76.9 (30/39) 73.9 (34/46) 75.4 (46/61) 75.0 (18/24)
DCR with PB-CT 0.102 0.265a 0.697a
  Yes 30.6 (26/64) 149.35 (±95.09) 33.3 (10/30) 47.1 (16/34) 39.1 (18/46) 44.4 (8/18)
  No 44.7 (38/64) 109.60 (±93.43) 66.7 (20/30) 52.9 (18/34) 60.9 (28/46) 55.6 (10/18)
TKI 0.287 0.227a 0.158a
  No 82.4 (70/85) 130.59 (±99.63) 76.9 (30/39) 87.0 (40/46) 78.7 (48/61) 91.7 (22/24)
  Yes 17.6 (15/85) 101.22 (±77.61) 23.1 (9/39) 13.0 (6/46) 21.3 (13/61) 8.3 (2/24)
DCR with TKI 0.818 1.000a 0.283a
  Yes 33.3 (5/15) 94.33 (±79.00) 33.3 (3/9) 33.3 (2/6) 38.5 (5/13) 0.0 (0/2)
  No 66.7 (10/15) 104.66 (±80.98) 66.7 (6/9) 66.7 (4/6) 61.5 (8/13) 100.0 (2/2)
a

Students t-test

b

χ2 test. Wood-smoke index=years exposed × no. of hours exposed. Tobacco smoke index=[(no. of cigarettes smoked per day) × (no. of years smoking)] / 20. EGFR, epidermal growth factor receptor; ECOG PS, eastern cooperative oncology group performance status; DCR, disease control rate; PB, platinum-based; CT, chemotherapy; TKI, tyrosine kinase inhibitor.